Patents
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
02/2003
02/13/2003WO2002038805A3 Eukaryotic cell division genes and their use in diagnosis and treatment of proliferative diseases
02/13/2003WO2002038793A9 Hepatitis c virus constructs characterized by high efficiency replication
02/13/2003WO2002037209A9 System, method, and computer software product for linked window interfaces
02/13/2003WO2002037101A3 A method to determine an engrafting cell dose of hematopoietic stem cell transplant units
02/13/2003WO2002033114A3 Protein-protein interactions in neurodegenerative diseases
02/13/2003WO2002032958A3 Polynucleotide and polypeptide sequences of human dendritic cell immunoreceptors
02/13/2003WO2002031115A3 Nucleic acid molecules and polypeptides for immune modulation
02/13/2003WO2002024323A3 High density molecular arrays on porous surfaces
02/13/2003WO2002018443A3 A recombinant monoclonal antibody to phosphotyrosine-containing proteins
02/13/2003WO2002015942A8 Method for the identification of agents that inhibit or promote cataracts and uses thereof
02/13/2003WO2002006534A3 Method of diagnosing pulmonary hypertension
02/13/2003WO2002006515A3 Method of diagnosing, monitoring, staging, imaging and treating colon cancer
02/13/2003WO2002001178A3 Electrochemical immunoassays using colloidal metal markers
02/13/2003WO2001098767A3 Testing apparatus for gas sensors
02/13/2003WO2001096023A3 Dielectrically-engineered microparticles
02/13/2003WO2001094951A9 Inhibitors of c-reactive protein induced inflammation
02/13/2003WO2001092567A3 Novel target genes for diseases of the heart
02/13/2003WO2001092331A8 Compositions and methods for the treatment of immune related diseases
02/13/2003WO2001070772A3 Molecule of pharmaceutical interest comprising at its n-terminal a glutamic acid or a glutamine in the form of an addition salt to an acid
02/13/2003US20030033630 Use of duckweed in high throughput screening
02/13/2003US20030033623 Animal model for use in the treatment and diagnosis of nervous system disorders
02/13/2003US20030033621 Transgenic animals and cell lines for screening drugs effective for the treatment or prevention of Alzheimer's disease
02/13/2003US20030033614 Method for identifying hormonally modulated genes
02/13/2003US20030033501 Processors for rapid sequence comparisons
02/13/2003US20030033279 Methods and apparatus for high-speed approximate sub-string searches
02/13/2003US20030033126 Modeling biological systems
02/13/2003US20030033092 Method and system for predicting initial analyte values in stored samples
02/13/2003US20030033091 Systems and methods for testing a biological sample
02/13/2003US20030032792 Nucleotide sequences coding polypeptide for use in the treatment, diagnosis and prevention of gastrointestinal, crohn's, inflammatory bowel, diabetes and cancer,
02/13/2003US20030032791 Nucleotide sequences coding polypeptide for use in the treatment of metabolic, reproductive and eating disorders
02/13/2003US20030032789 Nucleotide sequences coding enzymatic polypeptide for use as antiinflammatory agent
02/13/2003US20030032785 Detection of ligand and ligand sequences in sample; obtain nucleotide sequence samples, partitioning sample, incubate with primers, propagate and amplify sequences
02/13/2003US20030032775 Effector proteins of rapamycin
02/13/2003US20030032773 Proteins, genes and their use for diagnosis and treatment of bipolar affective disorder (BAD) and unipolar depression
02/13/2003US20030032769 Second mammalian tankyrase
02/13/2003US20030032649 Chimerizing protein kinases for drug discovery
02/13/2003US20030032636 For the treatment of depression and other affective disorders.
02/13/2003US20030032604 Smilagenin and its use
02/13/2003US20030032596 Administering a compound that modulates the synthesis or expression of a target cellular gene, especially a Src kinase.
02/13/2003US20030032595 Compositions and methods relating to glucose metabolism, weight control, and food intake
02/13/2003US20030032581 Pharmaceuticals for treating obesity
02/13/2003US20030032579 Therapeutic use of selective PDE10 inhibitors
02/13/2003US20030032576 Starting with a cellular metabolic network, a stoichiometric matrix is generated to describe the connectivity of the reaction in the network, where constraints can be placed on various fluxes to allow for defined inputs and outputs
02/13/2003US20030032203 Small molecule microarrays
02/13/2003US20030032202 Sensor surfaces for detecting analytes and methods of use
02/13/2003US20030032200 Proteins, genes and their use for diagnosis and treatment of bipolar affective disorder (BAD) and unipolar depression
02/13/2003US20030032199 Device and method for carrying out fluorescence immunotests
02/13/2003US20030032196 Test strip for a lateral flow assay for a sample containing whole cells
02/13/2003US20030032193 Particle analyzer and particle analyzing method
02/13/2003US20030032190 Mechanical mechanism for a blood glucose sensor dispensing instrument
02/13/2003US20030032189 Method and apparatus for calculating dew point, method and apparatus for compensating for dew point, MOS gas sensor system, and fuel cell system
02/13/2003US20030032184 Hepatocyte culture for use monitoring liver metabolism and diagnosing liver disorders
02/13/2003US20030032176 Helper-free stocks of recombinant adeno-associated virus vectors
02/13/2003US20030032168 Human ADAMTS-1 protein, gene encoding the same, pharmaceutical composition, and method for immunologically analyzing human ADAMTS-1 protein
02/13/2003US20030032166 Aortic carboxypeptidase-like protein and nucleic acids encoding same
02/13/2003US20030032160 Nucleotide sequences coding protein for use in treatment of cancer, inflammation, arthritis and psoriasis
02/13/2003US20030032156 Nucleotide sequences coding polypeptide for use in the treatment of cell proliferative disorders
02/13/2003US20030032155 Secreted and transmembrane polypeptides and nucleic acids encoding the same
02/13/2003US20030032138 Secreted and transmembrane polypeptides and nucleic acids encoding the same
02/13/2003US20030032135 Secreted and transmembrane polypeptides and nucleic acids encoding the same
02/13/2003US20030032119 Secreted and transmembrane polypeptides and nucleic acids encoding the same
02/13/2003US20030032097 DNA encoding human vanilloid receptor VR3
02/13/2003US20030032095 Novel nucleic acid sequences encoding human semaphorin-like polypeptides
02/13/2003US20030032088 Non-oligomerizing tandem fluorescent proteins
02/13/2003US20030032087 121P1F1: a tissue specific protein highly expressed in various cancers
02/13/2003US20030032085 An expression cassette comprising a transcriptional initiation region, consisting of a 5' non-coding region regulating the transcription of patched protein, a marker gene, and a transcriptional termination region
02/13/2003US20030032082 Isolation of preferential biological layer; obtain solid support, cover with biological film, incubate with substrate, expose to laser, recover biological layer
02/13/2003US20030032081 Detection of Helicobacter infection; obtain blood sample, record, administer labeled urea to human, obtain blood sample, expose to mass spectroscopy, amplified concentration of labeled in fluid indicates bacterial infection
02/13/2003US20030032080 Novel potentially fluorogenic compounds and plating media containing same
02/13/2003US20030032078 Screening therapies for vision defects; obtain sample containing oxidoreductase, incubate with modulator, monitor sample for reduction in enzyme activity
02/13/2003US20030032077 Recording medium and blood glucose monitoring system using the recording medium
02/13/2003US20030032076 Monitoring enzyme activity in sample; obtain enzyme sample, insert into resealable apparatus, expose to substrate, measure enzyme activity
02/13/2003US20030032074 Methods to determine prognosis after therapy for bladder cancer
02/13/2003US20030032073 Method for diagnosis and therapy of Hodgkin's lymphomas
02/13/2003US20030032072 Method for the assessment of allergenicity
02/13/2003US20030032071 Cell isolation and screening device and method of using same
02/13/2003US20030032070 Methods for diagnosing and treating alzheimer's disease and parkinson's disease
02/13/2003US20030032069 Evaluating neuropshychiatric diseases using a specimen-linked database
02/13/2003US20030032068 Anti-platelet immunoglobulin bead positive control
02/13/2003US20030032067 Test systems and sensors for detecting molecular binding events
02/13/2003US20030032065 Ensemble-based strategy for the design of protein pharmaceuticals
02/13/2003US20030032063 Secreted and transmembrane polypeptides and nucleic acids encoding the same
02/13/2003US20030032062 Secreted and transmembrane polypeptides and nucleic acids encoding the same
02/13/2003US20030032060 Secreted and transmembrane polypeptides and nucleic acids encoding the same
02/13/2003US20030032059 Gene recombination and hybrid protein development
02/13/2003US20030032057 Secreted and transmembrane polypeptides and nucleic acids encoding the same
02/13/2003US20030032056 Peptide fragmentation
02/13/2003US20030032054 Compositions and methods for monitoring the modification state of a pair of polypeptides
02/13/2003US20030032053 Generation of sensor apparatus; obtain electrode circuit board, form thin film over circuit board, electrodes and transducing element, recover sensor
02/13/2003US20030032052 Sequencing preferential nucleotide sequences; obtain pattern nucleotide sequence, join to substrate, incubate with reaction mixture, sequence pattern nucleotide sequences
02/13/2003US20030032048 Device for arraying biomolecules and for monitoring cell motility in real-time
02/13/2003US20030032047 Diagnosing an adenocarcinoma in a human; obtain sample, extract nucleotide sequences, incubate with marker probe, detect amplified gene expression of marker, evaluate for adenocarcinoma
02/13/2003US20030032046 Peelable and resealable devices for biochemical assays
02/13/2003US20030032045 Analyzing apoptosis regulation in eukaryotes; obtain cells, incubate with modulators of apoptosis, monitor cytochrome activity, compare to controls, evaluate apoptosis activity
02/13/2003US20030032044 Detection of urogenital disorders in humans; obtain biological sample, monitor cytokine expression, compare to wild type control, evaluate for urogenital disorders
02/13/2003US20030032043 Solid supports for use in the detection and measurement of biopolymers in sample
02/13/2003US20030032042 Internal calibration standards for electrophoretic analyses
02/13/2003US20030032041 Electrochemiluminescence helicase assay
02/13/2003US20030032040 Process of quality examining for microarray of biological material
02/13/2003US20030032039 Apparatus for detecting biochemical interactions occurring on a surface of a biosensor